Google, Meta, and Isomorphic Labs Invest $300 Million in Biohub’s Virtual Cell Initiative

Google DeepMind, Meta, and AI drug discovery startup Isomorphic Labs have committed $300 million to Biohub, the nonprofit biomedical research organization founded by Mark Zuckerberg and Priscilla Chan. The investment aims to accelerate the creation of a "virtual cell" capable of simulating biological processes digitally.

What Happened

The $300 million contribution from the three private entities is part of a broader $1.8 billion initiative to construct AI datasets that allow researchers to "ask, predict, and answer biological questions digitally." Biohub, established in 2016, has long sought to combat disease by developing a virtual cell model that enables scientists to run experiments without traditional wet-lab constraints.

In addition to the private sector funding, the project receives substantial support from the US government. The Department of Energy is investing more than $500 million over the next five years, while the National Institutes of Health is contributing datasets, repositories, and knowledge bases derived from previous federal investments totaling over $500 million.

Why It Matters

This collaboration highlights a growing convergence between frontier AI labs and biomedical research, where digital simulation is increasingly viewed as a critical tool for scientific discovery. By pooling resources from tech giants and federal agencies, the initiative seeks to overcome the data scarcity challenges inherent in biological modeling.

Alex Rives, Biohub’s head of science, stated in a press release that an accurate predictive model of biology could "dramatically accelerate scientific discovery by enabling scientists to perform experiments digitally." He described the creation of a virtual cell as "one of the most important challenges for the next era of science," emphasizing that it requires coordinated data generation at national and international scales.

The Bottom Line

The partnership between Google, Meta, Isomorphic Labs, and US federal agencies represents a major scaling-up of efforts to digitize biological research. The combined financial and data resources aim to make digital experimentation a viable standard for disease prevention and management.